When proteins start to make sense: fine-tuning of aminoglycosides for PTC suppression therapy

Moran Shalev, Timor Baasov

MedChemComm · 2014 · 43 citations · 101 references

DOIFull text

Open access

Concepts

Abstract

models of a variety of different diseases models underling by PTC mutations. Although these derivatives hold great promise to serve as therapeutic candidates they also demonstrate the necessity to further understand the molecular mechanisms of which AGs confer their biological activity in eukaryotic cells for further rational drug design. Recent achievements in structural research shed light on AGs mechanism of action and opened a new avenue in the development of new and improved therapeutic derivatives. The following manuscript highlights these accomplishments and summarizes their contributions to the state of art rational drug design.

References

101